Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong
· Delayed Price · Currency is HKD 0.810
0.00 (0.00%)
Apr 29, 2026, 3:16 PM HKT
HKG:3737 Revenue
In the year 2025, Zhongzhi Pharmaceutical Holdings had annual revenue of 1.74B CNY, down -21.55%. Zhongzhi Pharmaceutical Holdings had revenue of 857.01M in the half year ending December 31, 2025, a decrease of -10.31%.
Revenue
1.74B CNY
Revenue Growth
-21.55%
P/S Ratio
0.36
Revenue / Employee
760.72K CNY
Employees
2,284
Market Cap
699.52M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.74B | -477.30M | -21.55% |
| Dec 31, 2024 | 2.21B | 164.97M | 8.05% |
| Dec 31, 2023 | 2.05B | 223.88M | 12.26% |
| Dec 31, 2022 | 1.83B | 79.44M | 4.55% |
| Dec 31, 2021 | 1.75B | 142.62M | 8.89% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lee's Pharmaceutical Holdings | 1.44B |
| China NT Pharma Group Company | 26.88M |
| Pak Fah Yeow International | 214.28M |
| Fusen Pharmaceutical Company | 304.20M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.00B |
| Dawnrays Pharmaceutical (Holdings) | 1.37B |
| Essex Bio-Technology | 1.81B |